HŞHüseyin Şimşek

Hüseyin Şimşek

*This is an algorithmically generated author record based on publicly available information.

Hüseyin Şimşek has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antenatal Betamethasone Exposure at the Threshold of Viability: Survival and Neonatal Outcomes at 21–25 Weeks of Gestation

    by Mehtap Durukan Tosun, Cuma Tasin, Nihan Ozel Ercel, Huseyin Simsek, Mustafa Akcalı, Huseyin Durukan

    Introduction: Survival and short-term neonatal outcomes in preterm infants remain a significant clinical challenge. Although it is known that antenatal corticosteroids reduce neonatal mortality and morbidity when administered between 24 and 34 weeks of gestation, evidence regarding their use in borderline pregnancies is limited. The aim of this study was to evaluate the effect of antenatal betamethasone exposure on neonatal mortality and morbidity in infants born between 21 and 25 weeks of gestation. Materials and Methods: This retrospective study includes newborns born at Mersin City Training and Research Hospital between 1 January 2021 and 1 January 2026, at gestational ages ranging from 210/7 to 256/7 weeks, who underwent resuscitation in the delivery room and were admitted to the neonatal intensive care unit. Neonatal clinical and maternal characteristics, pregnancy and delivery characteristics, antenatal corticosteroid exposure, the need for respiratory support, neonatal morbidities, and mortality data were evaluated. The primary outcome was survival to discharge or transfer alive; secondary outcomes included recorded neonatal morbidities and their composites with death. Descriptive statistics were presented as medians (25th–75th percentiles), counts, and percentages. Group comparisons used the Kruskal–Wallis or Mann–Whitney U test for continuous variables and Fisher exact or Fisher–Freeman–Halton exact tests for binary categorical variables. Adjusted logistic regression assessed associations with clinical outcomes; sensitivity analyses included restriction to singleton infants. Sibling correlation was not accounted for in the 108-infant analysis. Results: The study included 108 preterm infants born at 21–25 weeks gestation. Thirty of the infants (27.8%) received a full/booster dose of betamethasone, 31 (28.7%) received an incomplete dose, and 47 (43.5%) did not receive betamethasone. Survival rates in the complete, incomplete, and no-betamethasone groups were 66.7%, 41.9%, and 14.9%, respectively (p < 0.001). In the main logistic regression model adjusted for gestational week, sex, and birth weight, compared with the group that did not receive betamethasone, incomplete exposure was associated with a 4.38-fold higher probability of survival, while complete exposure was associated with an 11.95-fold higher probability of survival. Incomplete and complete betamethasone exposure were associated with a lower likelihood of outcomes such as severe intraventricular hemorrhage or death. Complete exposure was also associated with a lower likelihood of the composite outcomes of necrotizing enterocolitis or death and retinopathy of prematurity or death. Conclusions: Antenatal betamethasone exposure in the management of periviable infants may offer potential benefits in terms of neonatal survival and morbidity. However, evaluating survival alone as a measure of a successful neonatal outcome is insufficient; serious neonatal morbidities and long-term neurodevelopmental outcomes must also be considered in the clinical decision-making process. To reduce uncertainty in this area, there is a need for studies with larger sample sizes, involving multiple centers, and including long-term follow-up.

  • Open Access

    Factors Associated with Antibiotic Initiation After DaBT-Hib-IPV Vaccination in NICU-Hospitalized Preterm Infants: The Role of C-Reactive Protein

    by Hüseyin Şimşek, Mustafa Akçalı, Mehtap Durukan Tosun, Berfin Özmen, Suna Özdem

    Objective: The purpose of this study was to evaluate the factors, particularly post-vaccination C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR), associated with the clinical decision to initiate antibiotic treatment following the 2-month diphtheria–acellular pertussis–tetanus–Haemophilus influenzae Type B–inactivated poliovirus (DaBT-Hib-IPV) vaccine in hospitalized infants. Methods: A retrospective review was conducted on the medical records of 46 infants. The study included infants hospitalized between 2022 and 2024 at Mersin City Training and Research Hospital who received the 2-month vaccine and subsequently underwent post-vaccination laboratory testing. Infants were categorized based on whether they received antibiotic treatment. Results: Antibiotics were administered to 20 infants, and 26 were observed without any treatment. Despite having a significantly higher gestational age (p = 0.027), the hospital stays of the antibiotic group were significantly longer (median 99 vs. 78 days, p < 0.001). C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR) were elevated in the antibiotic group (CRP = 2.82 vs. 1.63 mg/dL, p < 0.001; NLR= 0.90 vs. 0.72, p = 0.041). Culture positivity was low in antibiotic recipients (3/20, 15%). CRP was the only independent predictor of antibiotic administration when adjusted for gestational age and weight at vaccination (Exp(B) = 3.997, p = 0.003). Conclusions: In this cohort of NICU-hospitalized, predominantly preterm infants, a population that does not represent the general population of vaccinated 2-month-old infants, post-vaccination elevations in CRP and NLRs were associated with the clinical decision to initiate antibiotic treatment; however, in the absence of a validated infection reference standard, these markers cannot be assumed to reliably differentiate true infection from vaccine-induced inflammation. To prevent unnecessary antibiotic use and optimize patient management, these markers must be evaluated in conjunction with clinical findings, culture results, and supplementary biomarkers.

  • Open Access

    Experience with peripherally inserted central catheters in very low birth weight neonates: Indications, complications, and clinical outcomes

    by Mehtap Durukan Tosun, Sefika Aldas, Emine Sultan Yıldız, Huseyin Simsek, Mustafa Akcali, Mustafa Yildirim, Berfin Ozgokce Ozmen

    Objective: Vascular access is a critical factor in the monitoring and treatment of neonates requiring intensive care. In this context, peripherally inserted central catheters (PICCs) are one of the primary methods for safely and for extended periods in neonates, compared to traditional central vascular access routes. This study aimed to evaluate the indications and complications of PICC placement and to raise awareness of the development and implementation of protocols to prevent complications. Materials and Methods: In this study, after obtaining approval from the Ethics Committee, the indications, compositions, and clinical outcomes of patients born at Mersin City and Education Hospital between 01.01.2024-01.10.2025, weighing ≤1500 g and those who had peripheral central catheters left in place, were evaluated retrospectively. Results: A total of 89 patients were included in the study. Forty-nine cases were male (44.9 %). Forty-nine of the cases were 28 weeks of gestation or less. Thirty-three cases were inserted due to prematurity, forty-two due to feeding difficulties, and three due to pre/post-operative complications. The median PICC placement day was 5 d (4-12.5), and the median weight was 1020 g (780-1310). Nineteen cases developed complications related to PICCs. Among the complications, phlebitis was the most common (47.4%). Four patients required catheter removal due to infection. Nine patients (10.1%) died. Eighty patients (89.9%) were discharged after recovery. Conclusion: Peripherally inserted central catheters play a crucial role in neonatal intensive care by providing reliable, long-term venous access in neonates. When used with appropriate indications, strict aseptic technique, and standardized care protocols, they provide a healthy and safe vascular pathway for newborns with low complication and infection rates. A specialized team approach, guided by protocols, can enhance the quality of care in the neonatal intensive care unit.

  • Open Access

    Vancomycin-resistant Enterococcus colonization in newborns transferred after earthquake-related trauma: A retrospective analysis

    by Berfin Özgökçe Özmen, Şefika Aldaş, Mustafa Akçalı, Hüseyin Şimşek, Mehtap Durukan Tosun

  • Open Access

    Clinical Profile of Newborns with Down Syndrome: A Single-center Retrospective Analysis

    by Hüseyin Şimşek, Şefika Aldaş, Mustafa Akçalı, Berran Biçer, Mehtap Durukan Tosun

    Down syndrome (DS) is a genetic disorder characterized by intellectual disability and characteristic facial features. This study aimed to evaluate the demographic and clinical characteristics of newborns with a genetically confirmed diagnosis of DS who were admitted to the neonatal intensive care unit (NICU). This retrospective, descriptive study included 28 newborns with genetically confirmed DS who were admitted to the NICU of a tertiary care hospital between February 1, 2017, and April 30, 2025. Demographic and clinical data including sex, gestational age, birth weight, maternal and paternal ages, length of hospital stay, need for mechanical ventilation (MV) presence of congenital heart disease (CHD), hypothyroidism, prematurity, renal and abdominal ultrasonography (USG) findings, white blood cell (WBC) and platelet counts, and 1st- and 5th-minute APGAR scores were retrospectively reviewed. Of the 28 newborns, 53.6% were male and 46.4% were female. Prematurity occurred in 60.7% of cases. The mean gestational age was 35.5±2.9 weeks and the mean birth weight was 2590±619 g. Cesarean section was the delivery method in 78.6% of cases. The mean maternal and paternal ages were 36.5±6.6 and 41.5±6.5 years, respectively, with 71.4% of mothers aged over 35 years. CHD was detected in 96.4% of newborns, hypothyroidism in 53.6%, and pathological renal USG findings in 32.1%. CHD, hypothyroidism, and pathological renal USG findings were detected in 96.4%, 53.6%, and 32.1% of newborns, respectively. MV was required in 71.4% of patients, with a mean duration of 2±8.3 days. The mean hospital stay was 21.5±17.7 days. WBC counts were mostly normal, whereas thrombocytopenia occurred in 53.6% of subjects. Surfactant therapy was administered to one patient, and 50% of patients were diagnosed with sepsis. Two patients died during follow-up. Newborns with DS may present with multiple systemic complications at birth. Early detection of comorbidities, particularly CHD and endocrine disorders, is essential for treatment planning. Understanding neonatal characteristics in these patients may inform long-term management.

  • A Rare Case Report OF A Newborn That May Be Confused With Rickets Aad Other Metabolic Bone Dısorders: I-Cell Disease

    by Hüseyin Şimşek, Mustafa Akçalı, Mehtap Durukan Tosun, Mustafa Yıldırım

    I cell disease (Mucolipidosis II) is a rare autosomal recessive lysosomal storage disease characterised by severe skeletal abnormalities, intrauterine growth retardation, coarse facial appearance, progressive psychomotor retardation, thickening of the skin, gingival hyperplasia, hernias and early death. It is caused by a deficiency of N-acetylglucosamine 1-phosphotransferase which is normally found in the endoplasmic reticulum or Golgi apparatus. Since the clinical, biochemical and laboratory findings of the disease mimic rickets, the diagnosis may be difficult at the beginning

  • Open Access

    Adaptation of ventilation strategies from acute RDS to severe BPD: A national multicenter survey of practices in extremely preterm infants

    by Can Akyildiz, Funda Tüzün, Nuray Duman, Abdullah Bariş Akcan, Zeynep Alp Ünkar, Canan Aygün, Şenol Bozdağ, Özlem Bozkurt, Özgül Bulut, Ali Bülbül, et al.

    Advances in diagnostic and therapeutic methods have led to a paradigm shift in the management of bronchopulmonary dysplasia (BPD). The lack of evidence-based data in this area has led to variations in clinical practice. The aim of this study was to identify these differences and compare them with recommendations based on pathophysiology. The study was designed as an observational online survey of neonatologists from level 3 to 4 neonatal intensive care units caring for premature infants at increased risk of BPD and born before 28 weeks’ gestation. Respondents were invited to participate in the study through the portal of the Turkish Neonatal Society. Participants were surveyed online about preferred ventilation modes, settings and clinical management of these patients through each respiratory distress syndrome, evolving BPD and severe BPD phases. A total of 39 centers involved in the study. Pressure-control assist-control volume-guaranteed was the most commonly preferred ventilation mode in respiratory distress syndrome and evolving BPD, while high frequency oscillatory ventilation was most commonly used in severe BPD. The use of synchronized intermittent mandatory ventilation volume-guaranteed pressure support ventilation increased with disease progression. Ventilation settings were found to be changed according to pathophysiological recommendations, but not to the extent recommended. The study shows that early ventilation strategies are predominantly maintained in the later phases of BPD, although there are notable differences between centers.


  • Premature Infants have no Higher Risk of Atopy and Respiratory Functions Compared to Control at 4-6 Years of Age

    by Mehmet Satar, Tuğçe Güven, Hüseyin Şimşek, Derya Ufuk Altıntaş

    Aims: This study aimed to evaluate the respiratory functions and atopy conditions of preterm infants treated with aminophylline or caffeine for apnea in NICU in early childhood. Materials and Methods: This is a retrospective cohort study. In this study, 27 patients aged 4 to 6 years hospitalized in NICU for prematurity and 26 healthy children were included. The subjects were evaluated for fx5, phadiatope, total IgE levels, skin tests, and respiratory function tests. Results: There was no statistically significant difference among groups in terms of fx5, phadiatope, total IgE levels, and skin test results. Moreover, no statistically significant difference was found among the groups in terms of FVC, FEV1, FEV1/ FVC, PEF, MEF75, MEF50, MEF25, and MEF25-75 values in respiratory function tests. Preterm neonates with bronchopulmonary dysplasia (BPD) had higher FEV1 values compared to ones without BPD (p=0.02). Conclusion: Preterm infants treated with aminophylline or caffeine did not have a higher risk of atopy and had similar respiratory function tests compared to healthy infants at 4-6 years old. However, FEV1 values were higher in infants with BPD. These results suggested that respiratory functions could be affected in the long-term follow-up of premature infants with BPD.


  • Open Access

    Evaluation of side effects of ceftriaxone use in newborns

    by Mustafa Akçali, Hüseyin Şi̇mşek, Ferda Özlü, Hacer Yapicioğlu, Mehmet Satar

    Amaç: Seftriakson yan etkileri nedeniyle yenidoğanda sınırlı kullanıma sahiptir. Yenidoğan enfeksiyonlarında kullanımı ile ilgili sınırlı sayıda çalışma vardır. Bu çalışma ile setriakson alan yenidoğanlarda seftriakson sonrası oluşabilecek yan etkilerin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Çukurova Üniversitesi Tıp Fakültesi Balcalı Hastanesi Yenidoğan Yoğun Bakım Ünitesi’nde, 2015-2016 yılları arasında yatan bebeklerin seftriakson tedavisi öncesi ve sonrası klinik ve laboratuvar verileri retrospektif olarak incelenmiştir. Bulgular: Çalışmaya 30 olgu alınmıştır. Bu bebeklerin ortalama gebelik yaşı 37 ± 3,1 (30-41) hafta, seftriakson aldığı süre 7,2 ± 2,2 (2-12) gün bulunmuştur. 30 olgudan alınan idrar kültürlerinde; 17 (%56,6) bebekte üreme saptanmıştır. Bunların 11’inde (%36,6) Escherischia coli (E. coli), 5’inde (%16,7) diğer bakteriler üremiştir. Olguların seftriakson öncesi ve sonrası laboratuvar verilerinde kan üre azotu (BUN), total bilirubin (TB) ve hematokrit değerlerinde anlamlı düşüş saptanmıştır. Seftriakson kullanımına bağlı herhangi bir yan etki izlenmemiştir. Sonuç: Çalışmamızda seftriakson sonrası komplikasyon görülmemiş olması term veya terme yakın yenidoğanlarda seftriakson kullanımı için cesaret verici olabilir. Fakat, yenidoğanda seftriaksonun yan etkilerinin ve sıklıklarının kesinleştirilmesi ve yenidoğanda kullanılan diğer antibiyotiklere karşı alternatif olup olamayacağının belirlenmesi için daha fazla araştırmalara ihtiyaç vardır.